EUVIMEDEUVIMED entdecken
Multizentrische Studie

The Application of Adjuvant Radiotherapy in pN1 OSCC Patients Without Adverse Pathologic Features

Bo Li iD, Zhang Zhao, Yu Huang, Hanchen Zhou, Xue Zhang, Chuanbin Guo, Wei Wei, Na Ge, Wei Cao iD, Zhien Feng

Oral Diseases · 2025

DOI: 10.1111/odi.15336 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Oral Diseases, 2025. Verfasst von Bo Li und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oral and Maxillofacial-Head and Neck Oncology, Beijing Stomatological Hospital, Capital Medical University, Beijing, China. Hauptthemen laut MEDLINE: Mouth Neoplasms, Carcinoma, Squamous Cell. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 28 Literaturangaben. Gefördert von: Capital Medical University, the National Natural Science Foundation of China, the Beijing Science and Technology Commission.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

This study aimed to assess the necessity of adjuvant radiotherapy for oral squamous cell carcinoma patients with a pN1 stage and no adverse pathological features. Patients and Methods This was a multicenter cohort study including 231 patients.

Results

Among the enrolled patients, 171 received adjuvant radiotherapy, and 60 did not. According to the Kaplan–Meier survival analysis, there were no significant differences between the two groups in terms of disease‐free survival (59.5% vs. 58.3%, p = 0.938), overall survival (73.1% vs. 75.0%, p = 0.936), and disease‐specific survival (74.9% vs. 76.7%, p = 0.914). In patients with local/regional recurrence after surgery, after‐recurrence survival (34.8% vs. 44.0%, p = 0.197) was not significantly different. Analysis by T stage revealed no significant differences in disease‐free survival (60.9% vs. 75.0%, p = 0.084), overall survival (73.6% vs. 90.6%, p = 0.053) and disease‐specific survival (75.8% vs. 90.6%, p = 0.072) for T1‐2 patients between the radiotherapy and non‐radiotherapy groups. The results revealed statistically significant differences in disease‐free survival (57.9% vs. 39.3%, p = 0.030), overall survival (72.4% vs. 57.1%, p = 0.034) and disease‐specific survival (73.7% vs. 60.7%, p = 0.049) between the two groups.

Conclusions

Adjuvant radiotherapy does not improve the prognosis of T1‐2N1M0 patients without adverse pathological features; however, adjuvant radiotherapy should be recommended for T3‐4aN1M0 patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mouth NeoplasmsCarcinoma, Squamous CellHumansFemaleRadiotherapy, AdjuvantMaleMiddle AgedAgedAdultDisease-Free SurvivalNeoplasm Recurrence, LocalNeoplasm StagingAged, 80 and overKaplan-Meier EstimateRetrospective StudiesCohort Studies

Stichwörter der Autor:innen

OSCClymphatic invasionpN1perineural invasionradiotherapy

Autor:innen und Institutionen

  • Department of Oral and Maxillofacial-Head and Neck Oncology, Beijing Stomatological Hospital, Capital Medical University, Beijing, China.
  • Department of Oral and Maxillofacial and Head and Neck Oncology, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Department of Oral and Maxillofacial Surgery, Peking University School and Hospital of Stomatology, Beijing, China.
  • Clinical Epidemiology and EBM Unit, National Clinical Research Center for Digestive Diseases, Beijing Friendship Hospital, Capital Medical University, Beijing, China.

ORCID-Profile: Bo Li, Wei Cao

Förderung

  • Capital Medical University
  • the National Natural Science Foundation of China
  • the Beijing Science and Technology Commission
  • the Beijing Hospitals Authority Clinical Medicine Development
  • the Beijing Nova Program

Zitieren

APA

Li, B., Zhao, Z., Huang, Y., Zhou, H., Zhang, X., Guo, C., Wei, W., Ge, N., Cao, W., & Feng, Z. (2025). The Application of Adjuvant Radiotherapy in pN1 OSCC Patients Without Adverse Pathologic Features. Oral Diseases. https://doi.org/10.1111/odi.15336

Vancouver

Li B, Zhao Z, Huang Y, Zhou H, Zhang X, Guo C, et al. The Application of Adjuvant Radiotherapy in pN1 OSCC Patients Without Adverse Pathologic Features. Oral Diseases. 2025. doi:10.1111/odi.15336

BibTeX
@article{Li2025,
  author = {Li, Bo and Zhao, Zhang and Huang, Yu and Zhou, Hanchen and Zhang, Xue and Guo, Chuanbin and Wei, Wei and Ge, Na and Cao, Wei and Feng, Zhien},
  title = {The Application of Adjuvant Radiotherapy in pN1 OSCC Patients Without Adverse Pathologic Features},
  journal = {Oral Diseases},
  year = {2025},
  doi = {10.1111/odi.15336}
}
Kostenlos starten →